ConductScience.org, home

Trial · NCT01400542

Sleep Apnea in Early to Mid-Stage Alzheimer's Disease

NCT01400542, Terminated, Centre Hospitalier Universitaire de Saint Etienne

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Sleep Apnea in Early to Mid-Stage Alzheimer's Disease. Trials, record NCT01400542. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01400542

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
NCT number
NCT01400542
Status
Terminated
Enrollment
22 participants, actual
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Conditions
Early Onset Alzheimer Disease, Alzheimer Disease, Obstructive Sleep Apnea Syndromes
Interventions
CPAP Treatment, No treatment
First posted
2011-07-22
Last updated
2016-08-11

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryImpact of the CPAP treatment on cognitive functionsAt 4 Months
BADS zoo map scores : subjects are tested in two experimental settings, formulation and execution. The total execution time is the time taken to perform the task assigned in both conditions; the error score measures mistakes made during the test.
SecondaryRate of apnea/hypopnea events per hour (AHI/h)Each month from Day 1 to Month 4This secondary outcome measure is only for the treated group by CPAP.
SecondaryImpact of CPAP treatment on neuropsychological evaluation parametersAt 4 months
This impact is measured by theses following neuropsychological tests : MMS, clock drawing test, five-word test, Benton Visual Retention Test, Similarities Test (WAIS-R subtest), Coding test (WAIS-III subtest), digit and visual span tasks (forward and backward) from WAIS III, alphabetical and categorical verbal fluency tasks, part A and B of the Trail Making Test, and Stroop test. The consideration of these tests separately has no interest. The sum of these tests is important.
SecondaryImpact of the CPAP treatment on Quality of LifeAt 4 monthsIt measured by the QOL-AD questionnaire

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests4

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Clock Drawing TaskSecondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition
Trail Making Test ASecondary outcomeConductCognition
Verbal FluencySecondary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01400542

GET https://conductscience.org/api/trials/v1/NCT01400542/registered